Prosight Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-18,435	Closed	-$836K	–	53
2020 Q1	$836K	Buy	+18,435	New	+$836K	0.39%	35
2019 Q1	–	Sell	-20,198	Closed	-$1.71M	–	40
2018 Q4	$1.71M	Buy	+20,198	New	+$1.71M	0.88%	28